Cantargia AB (CHIX:CANTAS) Common Stock: kr19.9 Mil (As of Mar. 2026)


CHIX:CANTAS Cantargia AB CHIX:CANTAS
37 GF Score
Price kr4.17
! 2 Warning Signs
View Full Analysis

What is Cantargia AB Common Stock?

Cantargia AB CHIX:CANTAS 37 Common Stock is kr19.9 Mil as of Mar. 2026. GuruFocus rates CHIX:CANTAS with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

Cantargia AB's quarterly common stock stayed the same from Sep. 2025 (kr19.9 Mil) to Dec. 2025 (kr19.9 Mil) and stayed the same from Dec. 2025 (kr19.9 Mil) to Mar. 2026 (kr19.9 Mil).

Cantargia AB's annual common stock increased from Dec. 2023 (kr14.7 Mil) to Dec. 2024 (kr19.9 Mil) but then stayed the same from Dec. 2024 (kr19.9 Mil) to Dec. 2025 (kr19.9 Mil).


Cantargia AB Common Stock Historical Data

* Premium members only.

The historical data trend for Cantargia AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantargia AB Common Stock Chart

Cantargia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.02 13.36 14.70 19.89 19.89

Cantargia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.89 19.89 19.89 19.89 19.89
CHIX:CANTAS
37GF Score
Cantargia AB CHIX:CANTAS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantargia AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of kr19.9 Mil mean?
Cantargia AB (CHIX:CANTAS) has a Common Stock of kr19.9 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cantargia AB and its competitors.
Is Cantargia AB's Common Stock too high?
Cantargia AB's current Common Stock is kr19.9 Mil. Overall, Cantargia AB has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Cantargia AB's Common Stock compare to VRTX and REGN?
Cantargia AB's Common Stock of kr19.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cantargia AB and its competitors. Cantargia AB's current Common Stock is kr19.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantargia AB stock overvalued right now?
Cantargia AB (CHIX:CANTAS) has a current Common Stock of kr19.9 Mil. The current Common Stock is kr19.9 Mil. Cantargia AB's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Cantargia AB (CHIX:CANTAS), the current Common Stock is kr19.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantargia AB Business Description

Other Exchanges CANTA:Sweden7V3:Germany
Address Scheelevagen 27, Lund, SWE, 223 63
Cantargia AB is a Swedish biotech company that develops targeted antibody-based drugs for cancer as well as autoimmune and inflammatory diseases. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's development programme includes the candidate drugs nadunolimab (CAN04) and CAN10, both in the clinical development stage, which were latter acquired by Otsuka Pharmaceutical in 2025. In addition, the company is also developing a a pre-clinical project CAN14, derived from antibody platform CANxx. Geographically, the company's revenues have been generated in the markets of Japan and United States.
37GF Score

Get the complete analysis for CHIX:CANTAS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.17
Price